pretty much every biotech talks about chasing commercial deals...

  1. 664 Posts.
    lightbulb Created with Sketch. 260
    pretty much every biotech talks about chasing commercial deals or “being in discussions” with BP. Until there’s a tangible outcome to see I always take those claims with grain of salt, basically I take them as BS until proven otherwise. Why? Well, Very easy claims to make , investors like hearing them, just about plausible and impossible to disprove. All a biotech ceo needs to do is email somebody in BP or have a chat at a conference and that becomes “ in discussions with BP”.
    frankly after seeing for the first time on video that excruciating performance by this cat lady of a ceo - oozed charmlessness and mediocrity- if that’s the BIT figurehead trying to do deals over 20 years OMG!!!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $2.654M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $210 104.8K

Buyers (Bids)

No. Vol. Price($)
64 38848316 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 18281126 25
View Market Depth
Last trade - 12.28pm 27/06/2025 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.